Polaris Quantum Biotech, with a valuation of $40 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company uses the latest innovations in cloud and quantum computing, artificial intelligence, and machine learning to develop new drugs in a fraction of the time and cost of conventional methods. The platform and technology of Polaris Quantum Biotech scan billions of molecules from a large chemical space to find the molecules most suitable for drug development. Dr. Shahar Keinan and Bill Shipman founded Polaris Quantum Biotech in 2020. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,120,000. The campaign proceeds will be used for growth and expansion.
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.
Valuation History
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Employee History
Funding data not publicly available
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
Edge
$25 /month billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data